These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 32680737)

  • 21. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
    Araszkiewicz A; Sławek S; Trojnarska O; Lesiak M; Grygier M
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):159-164. PubMed ID: 29068141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device.
    Varotto L; Bregolin G; Paccanaro M; De Boni A; Bonanno C; Perini F
    Cerebrovasc Dis; 2020; 49(2):124-134. PubMed ID: 32289794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
    Sitwala P; Khalid MF; Khattak F; Bagai J; Bhogal S; Ladia V; Mukherjee D; Daggubati R; Paul TK
    Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-Market Clinical Follow-Up With the Patent Foramen Ovale Closure Device IrisFIT (Lifetech) in Patients With Stroke, Transient Ischemic Attack, or Other Thromboembolic Events.
    Sievert K; Yu J; Bertog S; Hornung M; von Bardeleben RS; Gafoor S; Reinartz M; Matic P; Hofmann I; Grunwald I; Schnelle N; Sievert H
    Cardiovasc Revasc Med; 2021 Sep; 30():72-75. PubMed ID: 33097460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
    Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
    Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Premere occlusion system for transcatheter patent foramen ovale closure: mid-term results of a single-center registry.
    Rigatelli G; Cardaioli P; Dell'avvocata F; Giordan M; Chinaglia M
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):564-9. PubMed ID: 20602480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent cerebrovascular events in patients after percutaneous closure of patent foramen ovale.
    Karagianni A; Mandalenakis Z; Dellborg M; Mirzada N; Johansson MC; Eriksson P
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104860. PubMed ID: 32430239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.
    Heinisch C; Bertog S; Wunderlich N; Majunke N; Baranowski A; Leetz M; Fischer E; Staubach S; Zimmermann W; Hofmann I; Sievert H
    EuroIntervention; 2012 Oct; 8(6):717-23. PubMed ID: 23086790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual shunting after percutaneous PFO closure: how to manage and how to close.
    Butera G; Sarabia JF; Saracino A; Chessa M; Piazza L; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):950-8. PubMed ID: 23804551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly.
    Takafuji H; Hosokawa S; Ogura R; Hiasa Y
    Heart Vessels; 2019 Oct; 34(10):1657-1662. PubMed ID: 30868214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
    Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M
    Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
    Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
    J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patent foramen ovale closure with the Gore septal occluder: initial UK experience.
    Thomson JD; Hildick-Smith D; Clift P; Morgan G; Daniels M; Henderson R; Spence MS; Mahadevan VS; Crossland D; Ormerod O
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):467-73. PubMed ID: 23766247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.